Skip to main content
Top
Gepubliceerd in: Neuropraxis 1/2012

01-02-2012

De genetica van de ziekte van Alzheimer

Auteurs: Renée de Bruijn, Arfan Ikram

Gepubliceerd in: Neuropraxis | Uitgave 1/2012

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Alzheimer’s disease is the most common subtype of dementia. In 2010 it was estimated that 36 million people where living with dementia worldwide and this number is expected to double every twenty years, because the population is aging. After many years of research there are still no therapeutic options to cure this devastating disease. One of the aims of genetic research in Alzheimer’s disease is to gain further insight in the exact pathogenesis of this disease and, ultimately, to contribute to developing new treatment possibilities. In recent years, the focus of genetic research in Alzheimer’s disease has shifted from small scale candidate gene studies to large scale Genome Wide Association Studies (GWAS). In this paper an overview is given of the development and current status of genetic research in Alzheimer’s disease.
Literatuur
2.
go back to reference Atkins, E.R. & Panegyres, P.K. (2011). The clinical utility of gene testing for Alzheimer’s disease.Neurology International, 3, e1. Atkins, E.R. & Panegyres, P.K. (2011). The clinical utility of gene testing for Alzheimer’s disease.Neurology International, 3, e1.
3.
go back to reference Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D. & Jones E. (2011). Alzheimer’s disease.Lancet, 377, 1019-1031.PubMedCrossRef Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D. & Jones E. (2011). Alzheimer’s disease.Lancet, 377, 1019-1031.PubMedCrossRef
4.
go back to reference Bekris, L.M., Yu, C.E., Bird, T.D. & Tsuang, D.W. (2010). Genetics of Alzheimer disease.Journal of Geriatric Psychiatry and Neurology, 23, 213-227.PubMedCrossRef Bekris, L.M., Yu, C.E., Bird, T.D. & Tsuang, D.W. (2010). Genetics of Alzheimer disease.Journal of Geriatric Psychiatry and Neurology, 23, 213-227.PubMedCrossRef
5.
go back to reference Bertram, L. & Tanzi, R.E. (2009). Genome-wide association studies in Alzheimer’s disease.Human Molecular Genetics, 18, R137-145.CrossRef Bertram, L. & Tanzi, R.E. (2009). Genome-wide association studies in Alzheimer’s disease.Human Molecular Genetics, 18, R137-145.CrossRef
6.
go back to reference Bettens, K, Sleegers, K. & Broeckhoven C. van (2010). Current status on Alzheimer disease molecular genetics: from past, to present, to future.Human Molecular Genetics, 19, R4-R11.CrossRef Bettens, K, Sleegers, K. & Broeckhoven C. van (2010). Current status on Alzheimer disease molecular genetics: from past, to present, to future.Human Molecular Genetics, 19, R4-R11.CrossRef
7.
go back to reference Corder, E.H., Saunders, A.M., Risch, N.J., et al. (1994). Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease.Nature Genetics, 7, 180-184.PubMedCrossRef Corder, E.H., Saunders, A.M., Risch, N.J., et al. (1994). Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease.Nature Genetics, 7, 180-184.PubMedCrossRef
8.
go back to reference Corder, E.H., Saundersm A,M., Strittmatter, W.J., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families.Science, 261, 921-923. Corder, E.H., Saundersm A,M., Strittmatter, W.J., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families.Science, 261, 921-923.
9.
go back to reference Eisenstein, M. (2011). Genetics: finding risk factors.Nature, 475, S20-22. Eisenstein, M. (2011). Genetics: finding risk factors.Nature, 475, S20-22.
10.
go back to reference Es, M.A. van & Berg, L.H. van den. Alzheimer’s disease beyond APOE.Nature Genetics, 41, 1047-1048. Es, M.A. van & Berg, L.H. van den. Alzheimer’s disease beyond APOE.Nature Genetics, 41, 1047-1048.
11.
go back to reference Ferri, C.P., Prince, M., Brayne, C., et al. (2005). Global prevalence of dementia: a Delphi consensus study.Lancet, 366, 2112-2117.PubMedCrossRef Ferri, C.P., Prince, M., Brayne, C., et al. (2005). Global prevalence of dementia: a Delphi consensus study.Lancet, 366, 2112-2117.PubMedCrossRef
12.
go back to reference Goate, A., Chartier-Harlin, M.C., Mullan, M., et al. (1991). Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease.Nature, 349, 704-706.PubMedCrossRef Goate, A., Chartier-Harlin, M.C., Mullan, M., et al. (1991). Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease.Nature, 349, 704-706.PubMedCrossRef
13.
go back to reference Gorelick, P.B., Scuteri, A., Black, S.E., et al. (2011). Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.Stroke, 42, 2672-2713.PubMedCrossRef Gorelick, P.B., Scuteri, A., Black, S.E., et al. (2011). Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.Stroke, 42, 2672-2713.PubMedCrossRef
14.
go back to reference Hardy, J. & Selkoe, D.J. (2002). The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics.Science, 297, 353-356.PubMedCrossRef Hardy, J. & Selkoe, D.J. (2002). The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics.Science, 297, 353-356.PubMedCrossRef
15.
go back to reference Hardy, J. (2006). A hundred years of Alzheimer’s disease research.Neuron, 52, 3-13. Hardy, J. (2006). A hundred years of Alzheimer’s disease research.Neuron, 52, 3-13.
16.
go back to reference Hardy, J., Myers, A. & Wavrant-De Vrieze, F. (2004). Problems and solutions in the genetic analysis of late-onset Alzheimer’s disease.Neurodegenerative Diseases, 1, 213-217.PubMedCrossRef Hardy, J., Myers, A. & Wavrant-De Vrieze, F. (2004). Problems and solutions in the genetic analysis of late-onset Alzheimer’s disease.Neurodegenerative Diseases, 1, 213-217.PubMedCrossRef
17.
go back to reference Harold, D., Abraham, R., Hollingworth, P., et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease.Nature Genetics, 41, 1088-1093. Harold, D., Abraham, R., Hollingworth, P., et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease.Nature Genetics, 41, 1088-1093.
18.
go back to reference Hollingworth, P., Harold, D., Simsm R., et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease.Nature Genetics, 43, 429-435. Hollingworth, P., Harold, D., Simsm R., et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease.Nature Genetics, 43, 429-435.
20.
go back to reference Jun, G., Najm A,C,, Beecham, G.W., et al. (2010). Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes.Archives of Neurology, 67, 1473-1484. Jun, G., Najm A,C,, Beecham, G.W., et al. (2010). Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes.Archives of Neurology, 67, 1473-1484.
21.
go back to reference Lambert, J.C. & Amouyel, P. (2011). Genetics of Alzheimer’s disease: new evidences for an old hypothesis?Current Opinion in Genetics & Development, 21, 295-301.CrossRef Lambert, J.C. & Amouyel, P. (2011). Genetics of Alzheimer’s disease: new evidences for an old hypothesis?Current Opinion in Genetics & Development, 21, 295-301.CrossRef
22.
go back to reference Lambert, J.C., Heath, S., Even, G., et al. (2009). Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease.Nature Genetics, 41, 1094-1049.PubMedCrossRef Lambert, J.C., Heath, S., Even, G., et al. (2009). Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease.Nature Genetics, 41, 1094-1049.PubMedCrossRef
23.
go back to reference Levy-Lahad, E., Wijsman, E.M., Nemens, E., et al. A familial Alzheimer’s disease locus on chromosome 1.Science, 269, 970-973. Levy-Lahad, E., Wijsman, E.M., Nemens, E., et al. A familial Alzheimer’s disease locus on chromosome 1.Science, 269, 970-973.
24.
go back to reference Morgan, K. (2011). The three new pathways leading to Alzheimer’s disease.Neuropathology and Applied Neurobiology, 37, 353-357.PubMedCrossRef Morgan, K. (2011). The three new pathways leading to Alzheimer’s disease.Neuropathology and Applied Neurobiology, 37, 353-357.PubMedCrossRef
25.
go back to reference Naj, A.C., Jun. G, Beecham, G.W., et al. (2011). Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer’s disease.Nature Genetics, 43, 436-441.PubMedCrossRef Naj, A.C., Jun. G, Beecham, G.W., et al. (2011). Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer’s disease.Nature Genetics, 43, 436-441.PubMedCrossRef
26.
go back to reference Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS) (2011). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales.Lancet, 357, 169-175. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS) (2011). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales.Lancet, 357, 169-175.
27.
go back to reference Poirier, J., Davignon, J., Bouthillierm D,, Kogan, S., Bertrandm P, & Gauthier, S. (1993). Apolipoprotein E polymorphism and Alzheimer’s disease.Lancet, 342, 697-699.PubMedCrossRef Poirier, J., Davignon, J., Bouthillierm D,, Kogan, S., Bertrandm P, & Gauthier, S. (1993). Apolipoprotein E polymorphism and Alzheimer’s disease.Lancet, 342, 697-699.PubMedCrossRef
28.
go back to reference Psaty, B.M., O’Donnell, C.J., Gudnason, V., et al. (2009). Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts.Circulation: Cardiovascular Genetics, 2, 73-80.CrossRef Psaty, B.M., O’Donnell, C.J., Gudnason, V., et al. (2009). Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts.Circulation: Cardiovascular Genetics, 2, 73-80.CrossRef
29.
go back to reference Rogaev, E.I., Sherrington, R., Rogaeva, E.A., et al. Familial Alzheimer’s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer’s disease type 3 gene.Nature, 376, 775-778. Rogaev, E.I., Sherrington, R., Rogaeva, E.A., et al. Familial Alzheimer’s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer’s disease type 3 gene.Nature, 376, 775-778.
30.
go back to reference Rogaeva, E., Meng, Y., Lee, J.H., et al. (2007). The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease.Nature Genetics, 39, 168-177.PubMedCrossRef Rogaeva, E., Meng, Y., Lee, J.H., et al. (2007). The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease.Nature Genetics, 39, 168-177.PubMedCrossRef
31.
go back to reference Rossor, M.N., Fox, N.C., Mummery, C.J., Schott, J.M. & Warren, J.D. (2010). The diagnosis of young-onset dementia.Lancet Neurology, 9, 793-806.PubMedCrossRef Rossor, M.N., Fox, N.C., Mummery, C.J., Schott, J.M. & Warren, J.D. (2010). The diagnosis of young-onset dementia.Lancet Neurology, 9, 793-806.PubMedCrossRef
32.
go back to reference Schellenberg, G.D. (1995). Genetic dissection of Alzheimer disease, a heterogeneous disorder.Proceedings of the National Academy of Sciences of the USA, 92, 8552-8559.PubMedCrossRef Schellenberg, G.D. (1995). Genetic dissection of Alzheimer disease, a heterogeneous disorder.Proceedings of the National Academy of Sciences of the USA, 92, 8552-8559.PubMedCrossRef
33.
go back to reference Schneider, J.A. & Bennett, D.A. (2010). Where vascular meets neurodegenerative disease.Stroke, 41, S144-146.CrossRef Schneider, J.A. & Bennett, D.A. (2010). Where vascular meets neurodegenerative disease.Stroke, 41, S144-146.CrossRef
34.
go back to reference Schneider, J.A., Arvanitakis, Z., Bang, W. & Bennett, D.A. (2007). Mixed brain pathologies account for most dementia cases in community-dwelling older persons.Neurology, 69, 2197-2204.PubMedCrossRef Schneider, J.A., Arvanitakis, Z., Bang, W. & Bennett, D.A. (2007). Mixed brain pathologies account for most dementia cases in community-dwelling older persons.Neurology, 69, 2197-2204.PubMedCrossRef
35.
go back to reference Seshadri, S., Fitzpatrick, A.L., Ikram, M.A., et al. (2010). Genome-wide analysis of genetic loci associated with Alzheimer disease.Journal of the American Medical Association, 303, 1832-1840.PubMedCrossRef Seshadri, S., Fitzpatrick, A.L., Ikram, M.A., et al. (2010). Genome-wide analysis of genetic loci associated with Alzheimer disease.Journal of the American Medical Association, 303, 1832-1840.PubMedCrossRef
36.
go back to reference Sherrington, R., Rogaev, E.I., Liang, Y., et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease.Nature, 375, 754-760. Sherrington, R., Rogaev, E.I., Liang, Y., et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease.Nature, 375, 754-760.
37.
go back to reference Verghese, P.B., Castellano, J.M. & Holtzman, D.M. (2011). Apolipoprotein E in Alzheimer’s disease and other neurological disorders.Lancet Neurology, 10, 241-252.PubMedCrossRef Verghese, P.B., Castellano, J.M. & Holtzman, D.M. (2011). Apolipoprotein E in Alzheimer’s disease and other neurological disorders.Lancet Neurology, 10, 241-252.PubMedCrossRef
Metagegevens
Titel
De genetica van de ziekte van Alzheimer
Auteurs
Renée de Bruijn
Arfan Ikram
Publicatiedatum
01-02-2012
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Neuropraxis / Uitgave 1/2012
Print ISSN: 1387-5817
Elektronisch ISSN: 1876-5785
DOI
https://doi.org/10.1007/s12474-012-0002-8

Andere artikelen Uitgave 1/2012

Neuropraxis 1/2012 Naar de uitgave

OriginalPaper

Woorden vooraf

OriginalPaper

Signalement